From: Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
BASELINE
(N = 14)
1 YEAR
(N = 13)
2 YEARS
P value
REST Global LVEF* (%)
Median
31.2
35.4
35.5
0.019
CCS† Median
3
2
<0.001
Ischemic Myocardium (%) Median
38.2
26.5
23.5
0.001